Health Care & Life Sciences » Biotechnology | Kitov Pharmaceuticals Holdings Ltd.

Kitov Pharmaceuticals Holdings Ltd. ADR | Balance Sheet

Fiscal year is January-December. All values ILS Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
669.90
5,109.50
41,081.70
56,409.70
26,388.00
24,976.40
Total Accounts Receivable
131.90
1,634.40
482.50
581.10
593.70
2,776.40
Other Current Assets
277.70
101.20
474.70
346.40
732.50
4,061.80
Total Current Assets
1,079.50
6,845.10
42,038.90
57,337.20
27,714.20
31,814.70
Net Property, Plant & Equipment
-
-
31.10
61.60
97.20
138.30
Intangible Assets
-
-
-
-
21,427.00
23,063.20
Total Assets
1,079.50
6,845.10
42,070.00
57,398.80
49,238.40
55,016.20
ST Debt & Current Portion LT Debt
3,113.50
-
-
-
-
Accounts Payable
187.40
1,945.70
1,373.50
1,982.10
746.40
Other Current Liabilities
1,062.10
1,587.70
3,287.90
2,917.30
13,376.30
Total Current Liabilities
4,363.00
3,533.40
4,661.50
4,899.30
14,122.70
Provision for Risks & Charges
-
-
719.80
985.30
1,708.10
Other Liabilities
-
-
-
-
3,575.80
Total Liabilities
4,363.00
3,533.40
5,381.30
5,884.60
19,406.50
Common Equity (Total)
3,283.60
3,311.60
36,688.70
51,514.20
25,388.20
Total Shareholders' Equity
3,283.60
3,311.60
36,688.70
51,514.20
25,388.20
Total Equity
3,283.60
3,311.60
36,688.70
51,514.20
29,831.90
Liabilities & Shareholders' Equity
1,079.50
6,845.10
42,070.00
57,398.80
49,238.40
Accumulated Minority Interest
-
-
-
-
4,443.70

About Kitov Pharmaceuticals Holdings

View Profile
Address
One Azrieli Center
Tel Aviv TA 670110
Israel
Employees -
Website http://www.kitovpharma.com
Updated 07/08/2019
Kitov Pharma Ltd. is a development stage biopharmaceutical company, which engages in drug development. The firm offers Consensi and NT219. Consensi is intended to treat osteoarthritis pain and hyper tension simultaneously, while NT219 is a cancer therapy drug that delivers anti-tumor effects and increasing survical in various cancer models.